Infliximab downregulates basic fibroblast growth factor and vascular endothelial growth factor in Crohn's disease patients. (Q47686523)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15113369 AND SRC:MED&resulttype=core&format=json

27 December 2019

title

Infliximab downregulates basic fibroblast growth factor and vascular endothelial growth factor in Crohn's disease patients (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15113369 AND SRC:MED&resulttype=core&format=json

27 December 2019

0 references

1 reference

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15113369 AND SRC:MED&resulttype=core&format=json

27 December 2019

Gino R Corazza

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15113369 AND SRC:MED&resulttype=core&format=json

27 December 2019

author name string

Ciccocioppo R

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15113369 AND SRC:MED&resulttype=core&format=json

27 December 2019

Benazzato L

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15113369 AND SRC:MED&resulttype=core&format=json

27 December 2019

Sturniolo GC

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15113369 AND SRC:MED&resulttype=core&format=json

27 December 2019

language of work or name

English

0 references

publication date

1 May 2004

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15113369 AND SRC:MED&resulttype=core&format=json

Alimentary Pharmacology & Therapeutics

27 December 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15113369 AND SRC:MED&resulttype=core&format=json

27 December 2019

volume

19

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15113369 AND SRC:MED&resulttype=core&format=json

27 December 2019

issue

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15113369 AND SRC:MED&resulttype=core&format=json

27 December 2019

page(s)

1019-1024

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15113369 AND SRC:MED&resulttype=core&format=json

A short-term study of chimeric monoclonal antibody cA2 to tumor necrosis factor alpha for Crohn's disease. Crohn's Disease cA2 Study Group.

27 December 2019

cites work

1 reference

https://api.crossref.org/works/10.1111/J.1365-2036.2004.01927.X

Infliximab for the treatment of fistulas in patients with Crohn's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.1365-2036.2004.01927.X

Infliximab but not etanercept induces apoptosis in lamina propria T-lymphocytes from patients with Crohn's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.1365-2036.2004.01927.X

Defective mucosal T cell death is sustainably reverted by infliximab in a caspase dependent pathway in Crohn's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.1365-2036.2004.01927.X

Review article: the clinical role of anti-TNFalpha antibody treatment in Crohn's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.1365-2036.2004.01927.X

Serum basic fibroblast growth factor in pediatric Crohn's disease. Implications for wound healing

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.1365-2036.2004.01927.X

Increased Serum Levels of Vascular Endothelial Growth Factor in Patients with Inflammatory Bowel Disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.1365-2036.2004.01927.X

Myocardial extracellular matrix remodeling in transgenic mice overexpressing tumor necrosis factor alpha can be modulated by anti-tumor necrosis factor alpha therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.1365-2036.2004.01927.X

Maintenance infliximab for Crohn's disease: the ACCENT I randomised trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.1365-2036.2004.01927.X